Skip to content

Drug interactions

Idarubicin + Trastuzumab

Severity: Major

Idarubicin and Trastuzumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Trastuzumab-associated cardiomyopathy is more frequent and severe when combined with or given after anthracyclines. Idarubicin shares the cardiotoxic class effect, so the combination carries a significant risk of heart failure.

What this interaction means in plain words

Idarubicin and Trastuzumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Idarubicin belongs to Oncology; Trastuzumab belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive cardiotoxicity from anthracycline myocyte damage and HER2 signaling blockade.

What to do

Avoid concurrent use where possible and check LVEF at baseline and regularly. Stop or hold treatment if LVEF drops or heart failure develops.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Idarubicin and Trastuzumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Idarubicin with Trastuzumab?

MediHelp rates the interaction as major. Idarubicin and Trastuzumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Trastuzumab-associated cardiomyopathy is more frequent and severe when combined with or given after anthracyclines. Idarubicin shares the cardiotoxic class effect, so the combination carries a significant risk of heart failure.

How serious is the interaction between Idarubicin and Trastuzumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and check LVEF at baseline and regularly. Stop or hold treatment if LVEF drops or heart failure develops.

What other medicines interact with Idarubicin?

MediHelp also lists interactions of Idarubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclophosphamide. The full list is on the Idarubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in